City National Bank’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$122K Sell
21,557
-200,250
-90% -$1.65M ﹤0.01% 799
2015
Q2
$2.46M Sell
221,807
-419,107
-65% -$5.4M 0.02% 355
2015
Q1
$10.1M Buy
640,914
+151,950
+31% +$2.35M 0.08% 215
2014
Q4
$7.44M Buy
488,964
+39,770
+9% +$483K 0.06% 238
2014
Q3
$4.84M Buy
449,194
+21,896
+5% +$286K 0.04% 267
2014
Q2
$6.53M Buy
427,298
+220,009
+106% +$3.17M 0.06% 241
2014
Q1
$3.75M Buy
207,289
+57,025
+38% +$1.1M 0.05% 243
2013
Q4
$2.09M Buy
150,264
+62,620
+71% +$721K 0.03% 305
2013
Q3
$919K Sell
87,644
-8,450
-9% -$83.9K 0.02% 404
2013
Q2
$750K Buy
+96,094
New +$838K 0.01% 452

Other funds holding SGMO

City National Bank's SGMO Position: Q3 2015 in Review

City National Bank reduced its SANGAMO THERAPEUTICS INC (SGMO) stake by 90% in Q3 2015, selling an estimated $1.65M and leaving 21,557 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #799.

City National Bank first reported a position in SGMO in Q2 2013 and has held it in 10 quarters since. The position peaked at $10.1M in Q1 2015. 141 funds tracked by Wall St. Rank hold SGMO as of Q3 2015.

  • City National Bank held 21,557 shares of SANGAMO THERAPEUTICS INC worth $122K as of Q3 2015.
  • City National Bank sold 200,250 SANGAMO THERAPEUTICS INC shares in Q3 2015, an estimated $1.65M.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of City National Bank's portfolio in Q3 2015, its #799 holding.
  • City National Bank first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 10 quarters since.
  • City National Bank's SANGAMO THERAPEUTICS INC position peaked at $10.1M in Q1 2015.
  • 141 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.